SCHEMBL6966789

SCHEMBL6966789

[C-]#[N+]C(CCCc1ccccc1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.49
▸ CNR2 P34972 3/20 0.46
▸ BCHE P06276 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MMP1 P03956 4/20 0.42
▸ MMP2 P08253 4/20 0.42
▸ MMP3 P08254 4/20 0.42
▸ PDE4A P27815 4/20 0.42
▸ PDE4B Q07343 4/20 0.42
▸ PDE4C Q08493 4/20 0.42
▸ PDE4D Q08499 4/20 0.42
▸ FKBP1A P62942 1/20 0.42
▸ FDFT1 P37268 1/20 0.41
▸ MCHR1 Q99705 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6220362 0.83 ALDH1A1 (0.42) ALDH1A1CNR2BCHEACHECA12
SCHEMBL1307134 0.82 CA2 (0.48) ALDH1A1CNR2BCHEACHECA12
SCHEMBL186606 0.81 CA12 (0.43) ALDH1A1CNR2CA12CYP3A4CA9
SCHEMBL29956354 0.81 MCHR1 (0.44) ALDH1A1CNR2CA12CYP3A4CA9
SCHEMBL31106597 0.80 MCHR1 (0.47) ALDH1A1CNR2CA12CYP3A4ATM
SCHEMBL31106589 0.80 MCHR1 (0.47) ALDH1A1CNR2CA12CYP3A4ATM
SCHEMBL9404416 0.77 CA12 (0.49) ALDH1A1CA12CYP3A4CA9MMP1
SCHEMBL10420695 0.77 MMP2 (0.55) ALDH1A1CNR2MMP1MMP2MMP3
SCHEMBL11354319 0.76 GAA (0.39) ALDH1A1CA12CYP3A4CA9MMP1
SCHEMBL10420884 0.76 MMP2 (0.54) ALDH1A1CNR2MMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1178981-B1 SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLES, AND RELATED THERAPEUTIC AND PROPHYLACTIC METHODS ORTHO MCNEIL PHARM INC (US) 2003-06-25 — — EP disclosed
US-6562843-B1 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-05-13 — — US disclosed
EP-1178981-A1 SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLES, AND RELATED THERAPEUTIC AND PROPHYLACTIC METHODS Ortho-Mcneil Pharmaceutical, Inc. (US) 2002-02-13 — — EP disclosed
WO-2000069847-A1 SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLES, AND RELATED THERAPEUTIC AND PROPHYLACTIC METHODS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-11-23 — — WO disclosed
Send feedback